Combination of Rituximab

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
63	特発性血小板減少性紫斑病	5

63. 特発性血小板減少性紫斑病

臨床試験数 : 391 / 薬物数 : 235 - (DrugBank : 50) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 139

trials per page:

Showing 1 to 5 of 5 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05338190 (ClinicalTrials.gov)	June 1, 2022	21/3/2022	Efficacy and Safety ofSubcutaneous Belimumab or Placebo in Addition of Rituximabin Persistent or Chr ...	A Phase 3 Randomized and Double-blind Controlled Trial Comparing the Efficacy and Safety ofSubcutane ...	Primary Immune Thrombocytopenia (ITP)	Drug: Combination of Rituximabwith subcutaneous belimumab;Drug: Combination of Rituximabwith subcuta ...	Assistance Publique - Hôpitaux de Paris	GlaxoSmithKline	Not yet recruiting	18 Years	N/A	All	132	Phase 3	NULL
2	NCT01525836 (ClinicalTrials.gov)	May 2011	31/1/2012	rhTPO Combining Rituximab Versus Low-dose Rituximab in Management of ITP	Recombinant Human Thrombopoietin in CombinationWith RituximabVersus Low-dose Rituximabfor the Treatm ...	Purpura;Idiopathic Thrombocytopenic Purpura	Drug: rituximab; recombinant human thrombopoietin (rhTPO);Drug: Rituximab	Shandong University	The Affiliated Hospital ofthe Chinese Academy ofMilitary Medical Sciences;The First Affiliated Hospi ...	Completed	18 Years	72 Years	Both	123	Phase 3	China
3	NCT01506414 (ClinicalTrials.gov)	June 2009	16/11/2011	Recombinant Human Thrombopoietin in Combination With Rituximab in Immune Thrombocytopenia (ITP)	A Multicentre Investigation ofRecombinant Human Thrombopoietin (Rh-TPO) Combine With Low-dose Rituxi ...	Purpura;Idiopathic Thrombocytopenic Purpura	Drug: rhTPO in combination with Rituximab	Ming Hou	Peking Union Medical College Hospital;Chinese Academy ofMedical Sciences;First Affiliated Hospital, ...	Completed	16 Years	75 Years	Both	91	Phase 3	China
4	NCT00909077 (ClinicalTrials.gov)	August 2004	26/5/2009	The Efficacy ofDexamethasone Versus Dexamethasone Combined With Rituximabin Patients With Newly Diag ...	A Randomised Phase III Study ofthe Efficacy ofHigh Dose Dexamethasone Versus High Dose Dexamethasone ...	Idiopathic Thrombocytopenic Purpura	Drug: Dexamethasone;Drug: Dexamethasone and Rituximab	Copenhagen University Hospital at Herlev	NULL	Completed	18 Years	N/A	All	155	Phase 3	Denmark
5	NCT00161564 (ClinicalTrials.gov)	February 2004	8/9/2005	A Trial to Treat Patients With ITP Who Do Not Achieve a Durable Response to Rituxan Alone	A Randomized Trial Comparing Higher Doses of Rituximab(Rituxan) With Standard Doses ofRituxan in Com ...	Idiopathic Thrombocytopenic Purpura (ITP)	Drug: Rituximab	Weill Medical College of Cornell University	Genentech, Inc.	Withdrawn	12 Years	N/A	All	0	Phase 2	United States

First Previous1Next Last